Overview
Updated 14 Jul 2026
Victor Tapson, MD, is Vice President of Medical Affairs, Inari Medical. The public record shows 539 publications with 55,237 citations (h-index 95), centered on Venous Thromboembolism Diagnosis and Management, Pulmonary Hypertension Research and Treatments, Atrial Fibrillation Management and Outcomes. It also documents an investigator role on 8 registered clinical trials, industry payments reported by 14 companies.
- Most recent indexed publication: 2022 · American journal of respiratory and critical care medicine
- Top research focus: Venous Thromboembolism Diagnosis and Management
- 8 registered trials on ClinicalTrials.gov
- Open Payments reporting from 14 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 4 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 269.
Clinical & industrytrials, payments and federal funding
Federally funded research awards.
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:
- Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism
Sponsor: Victor Tapson, MD
InvestigatorPhase 4TerminatedNCT03988842 - Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension (RELIEVE-PAH)
Sponsor: V-Wave Ltd
InvestigatorActive, not recruitingNCT03838445 - FlowTriever Pulmonary Embolectomy Clinical Study
Sponsor: Inari Medical
InvestigatorCompletedNCT02692586
Industry payments
Updated 14 Jul 2026
14 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Stryker CorporationProgram year20255 payments
- AngioDynamics, Inc.Program year20251 payment
- Inquis Medical, Inc.Program year20253 payments
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial.
American journal of respiratory and critical care medicine
2022 - Direct oral anticoagulants in chronic thromboembolic pulmonary hypertension.
Journal of thrombosis and thrombolysis
2021
Most-cited worksby citation count (OpenAlex)
- 01Remdesivir for the Treatment of Covid-19 — Final Report7,735 citations2020
- 02
- 03ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension2,356 citations2009
- 04Antithrombotic Therapy for Venous Thromboembolic Disease2,052 citations2001
- 05Baricitinib plus Remdesivir for Hospitalized Adults with Covid-191,921 citations2020
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
127 S. San Vicente Blvd, Smidt Heart Institute, Suite 3600, Los Angeles, CA 90048
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →evtoday.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →google.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →google.com ↗
- Board certified
Internal Medicine and Pulmonary Disease; fellowship-trained in Pulmonary and Critical Care
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →novapublishers.com ↗
Editorial & leadership rolesjournal and society appointments
- Committee member
World Pulmonary Hypertension Consensus Guidelines (since 2003); CTEPH subcommittee
2003provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cedars-sinai.org ↗ - Founding elected President
The PERT Consortium (Pulmonary Embolism Response Team Consortium)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pertconsortium.org ↗ - Chairman
American Thoracic Society (ATS) Consensus Statement on the Diagnostic Approach to Acute Venous Thromboembolism; contributor to ATS VTE diagnosis clinical practice guidelines
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchers.cedars-sinai.edu ↗
Secondary affiliationsappointments beyond the home institution
- Associate Director
Pulmonary and Critical Care Division; Director, Venous Thromboembolism (VTE) Research; Professor of Medicine, Cedars-Sinai Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cedars-sinai.org ↗ - Former Professor of Medicine and 20-year Director
Duke Pulmonary Vascular Disease Center; cofounder, Duke Lung Transplant Program and Duke CTEPH Program (Duke University Medical Center, prior institution)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →evtoday.com ↗
Media & interviewspress, podcasts and appearances
- Podcast guest
"I'm Aware That I'm Rare" (phaware), multiple episodes on pulmonary hypertension and CTEPH
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →themighty.com ↗ - Podcast guest
"Medicine, We're Still Practicing" (CurtCo Media), episode on shortness of breath
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →curtco.com ↗ - Video interview
"Dr. Victor Tapson: Care Teams, PE, VTE, and New Trials", Docwire News
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →docwirenews.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/victor-tapson-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/victor-tapson-1105b312
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Victor-Tapson-2
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by otherswhere others cite or feature them
- Other
ir.inarimedical.com/news-releases/news-release-details/inari-medical-appoints-pulmonologist-dr-victor-f-tapson-vp
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ir.inarimedical.com ↗ - Other
researchers.cedars-sinai.edu/Victor.Tapson
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchers.cedars-sinai.edu ↗ - Other
cedars-sinai.org/provider/victor-tapson-1549902.html
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cedars-sinai.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this specialty yet.